Name: Emyria (EMD) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

EMD

Health Care Equipment & Services

Emyria

Short interest: 0.00%; 0.00 pp 30d; as of 8 Oct 2026
Reported shorts: 6.4K
Shares on issue: 806.686M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Emyria

Emyria operates a network of specialist medical clinics focused on collecting and commercializing clinical data. The company leverages proprietary software to gather anonymized patient data, which is then used to generate clinical evidence. This positions Emyria uniquely in the healthcare sector, combining medical services with data-driven insights.

Company profile →

Emyria (ASX:EMD) has 0.00% of its shares on issue reported as short positions as of 8 Oct 2026, or about 6,369 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.10% in February 2020. EMD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads EMD today

Zanger BreakoutWatchScore 32rank 549 of 1942
CAN SLIMWatchScore 10rank 1047 of 1541
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutWatchScore 10rank 983 of 1502
Quality compoundersWatchScore 10rank 1186 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

EMD fundamentals

In the year to 30 Jun 2026, Emyria (ASX:EMD) recorded revenue of A$4.1M and a net loss after tax of A$6.1M. A year earlier it recorded revenue of A$1.4M and a net loss after tax of A$3.1M. Year-on-year growth: revenue +190.6% (FY). Net margin −150.8% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →